My concern is this: CytoBioscience completed a reverse merger with WASM to be able to raise new capital to fund their growing business. Unfortunately, ever since the reverse merger was completed the stock price has continued to decline. I am confused as to why a company would go through so much trouble to complete such a transaction and then not take advantage of it. I do not expect to get my money back on this stock and I don't mean to be so pessimistic but they have had plenty of time to give us some positive news/updates. Crickets....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.